Pro: Vedolizumab Should Be Used Before Anti-Tnfs For Moderate To Severe Ibd

PRO: Vedolizumab should be used before anti-TNFs for moderate to severe IBD

CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD

The treatment of moderate to severe IBD with anti-TNF biologics and immunomodulators

Key Insights: Reaching Beyond Anti-TNFs in Moderate to Severe Ulcerative Colitis

CON: We are not yet ready to use Vedolizumab in Pediatric IBD

Should We Change How we Position Biologics for Use in Crohn’s Disease?

Vedolizumab Safe for Inflammatory Bowel Disease – IBD in the News

When and How to Use Immunomodulators and Biologics in IBD

How will future therapeutic pathways change for ulcerative colitis and Crohn's disease?

PRO: We are ready to use Vedolizumab in Pediatric IBD

Vedolizumab as a treatment for Crohn’s Disease: Efficacy and safety

Should We Change How We Position Biologics for Use in Ulcerative Colitis?

Understanding the Risks and Benefits of IBD Therapies

Animated IBD Patient

Positioning of Biologics and New Therapeutics for Crohn's Disease

Duration of Crohn's Disease & Response to Vedolizumab Entyvio

Update on vedolizumab in IBD: What have we learned?

First line therapies for ulcerative colitis and Crohn's disease

Use of anti-TNF therapies for Crohn's disease

Chronic Inflammation in IBD and How Anti-TNF Therapy Works

Animated IBD Patient

Inflammatory Bowel Diseases: Ulcerative Colitis | UCLA Digestive Diseases